Featured Research

from universities, journals, and other organizations

National Jewish Receives NIH Grant To Study Fibrotic Lung Disease

Date:
June 23, 1997
Source:
National Jewish Medical And Research Center
Summary:
The National Heart, Lung and Blood Institute at the National Institutes of Health have awarded National Jewish Medical and Research Center a $9 million Specialized Center of Research grant to study the pathogenesis and treatment of pulmonary fibrosis.

CONTACT: Jordan Gruener
(303) 398-1002


National Jewish Medical and Research Center Receives
$9 Million Grant From NIH to Study Fibrotic Lung Disease


The National Heart, Lung and Blood Institute at the National Institutes of Health have awarded National Jewish Medical and Research Center a $9 million Specialized Center of Research grant to study the pathogenesis and treatment of pulmonary fibrosis.

The grant is $1.8 million a year for 5 years. This work will be part of the clinical and research program of the Pulmonary and Critical Care Division of the University of Colorado Health Sciences Center.
"We need to learn more about the basic mechanisms of fibrosis," said Robert Mason, M.D., a National Jewish physician and principal investigator of the study. "We’re focusing on inflammation and growth factors as regulators of the fibrotic response."


People with pulmonary fibrosis, also known as interstitial lung disease, generally suffer from cough. Scarring in the lungs, caused by the disease, makes the lungs stiff and causes shortness of breath.


"We’re trying to prevent continued scar formation in the lungs," Dr. Mason said. "Pulmonary fibrosis is a devastating disease, like cancer, with a high mortality rate."
National Jewish will continue its basic studies on the mechanism of pulmonary fibrosis and initiate clinical trials aimed at limiting the fibrotic response. Kevin Brown, M.D., of National Jewish, will head the clinical patient assessment and be responsible for controlled clinical trials. This work will be performed in collaboration with physicians and investigators at the University of Colorado.

National Jewish researchers are conducting four interstitial lung disease research projects. The research projects include:

• The role of T cells in inducing pulmonary fibrosis
• Interactions between the epithelium and the mesenchyme—a network of cells—during lung injury and treatment
• Regulation of the paroduction of fibrogenic growth factors by macrophages
• A clinical trial using interferon gamma to control inflammation in the lungs and to control the fibrotic response


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "National Jewish Receives NIH Grant To Study Fibrotic Lung Disease." ScienceDaily. ScienceDaily, 23 June 1997. <www.sciencedaily.com/releases/1997/06/970623135338.htm>.
National Jewish Medical And Research Center. (1997, June 23). National Jewish Receives NIH Grant To Study Fibrotic Lung Disease. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/1997/06/970623135338.htm
National Jewish Medical And Research Center. "National Jewish Receives NIH Grant To Study Fibrotic Lung Disease." ScienceDaily. www.sciencedaily.com/releases/1997/06/970623135338.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins